Donaldson (NYSE: DCI) director reports 3,000-share option grant, 900 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Donaldson Company director reports new stock and option awards. On 01/02/2026, the reporting person acquired 900 shares of Donaldson common stock at a stated price of $0, bringing directly held common shares to 1,000.
The same day, the director received a stock option to buy 3,000 shares of Donaldson common stock at an exercise price of $89.93 per share. The option expires on 01/02/2036 and will vest in three equal annual installments beginning on January 2, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Shine Daniel P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,000 | $0.00 | -- |
| Grant/Award | Common Stock | 900 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 3,000 shares (Direct);
Common Stock — 1,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Donaldson (DCI) report in this Form 4?
A company director reported acquiring 900 shares of common stock at a stated price of $0 and receiving a stock option for 3,000 shares on 01/02/2026.
What are the key terms of the new stock option granted by Donaldson (DCI)?
The director received a stock option to buy 3,000 shares of Donaldson common stock at an exercise price of $89.93 per share, expiring on 01/02/2036.
When does the new Donaldson (DCI) stock option begin vesting and how?
The option vests in three equal annual installments, beginning on January 2, 2027, as disclosed in the explanation of responses.
What is the reporting person’s relationship to Donaldson (DCI)?
The reporting person is listed as a Director of Donaldson Company Inc. on the Form 4.
Is this Donaldson (DCI) Form 4 filed for one insider or multiple insiders?
The filing indicates it is a Form filed by one reporting person, not a joint filing.